We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.91B
AUM Growth
+$61.2M
Cap. Flow
+$64.4M
Cap. Flow %
2.22%
Top 10 Hldgs %
30.43%
Holding
226
New
26
Increased
31
Reduced
48
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$41M
2
ABT icon
Abbott
ABT
+$37M
3
MRNA icon
Moderna
MRNA
+$32.5M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29.2M
5
GILD icon
Gilead Sciences
GILD
+$26.5M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$60.5M
2
BDX icon
Becton Dickinson
BDX
+$22.1M
3
HUM icon
Humana
HUM
+$18.1M
4
TECH icon
Bio-Techne
TECH
+$16.1M
5
NVCR icon
NovoCure
NVCR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 95.75%
2 Real Estate 2.99%
3 Industrials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
76
BioMarin Pharmaceuticals
BMRN
$11.6B
$9.67M 0.33%
128,004
-150,326
-54% -$12.3M
SRPT icon
77
Sarepta Therapeutics
SRPT
$1.68B
$9.61M 0.33%
128,987
-77,500
-38% -$7.15M
UHS icon
78
Universal Health Services
UHS
$10.2B
$9.51M 0.33%
+71,323
New +$9.46M
GTHX
79
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$9.43M 0.32%
+391,754
New +$9.1M
TBPH icon
80
Theravance Biopharma
TBPH
$874M
$9.31M 0.32%
456,296
– –
MOH icon
81
Molina Healthcare
MOH
$10.2B
$9.3M 0.32%
39,769
– –
GRTX
82
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$9.19M 0.32%
1,041,845
– –
ZTS icon
83
Zoetis
ZTS
$32.3B
$8.9M 0.31%
56,521
– –
SBRA icon
84
Sabra Healthcare REIT
SBRA
$5.2B
$8.87M 0.3%
510,660
– –
ARWR icon
85
Arrowhead Research
ARWR
$12.1B
$8.81M 0.3%
132,886
– –
MPT
86
Medical Properties Trust
MPT
$2.75B
$8.76M 0.3%
411,743
– –
DOC
87
DELISTED
PHYSICIANS REALTY TRUST
DOC
$8.76M 0.3%
495,733
– –
INCY icon
88
Incyte
INCY
$24B
$8.75M 0.3%
107,687
+14,430
+15% +$1.23M
DNLI icon
89
Denali Therapeutics
DNLI
$3.67B
$8.57M 0.29%
150,086
+77,753
+107% +$5.2M
ACAD icon
90
Acadia Pharmaceuticals
ACAD
$4.39B
$8.56M 0.29%
331,789
– –
SAGE
91
DELISTED
Sage Therapeutics
SAGE
$8.54M 0.29%
114,119
-37,921
-25% -$3.11M
CTLT
92
DELISTED
CATALENT, INC.
CTLT
$8.43M 0.29%
+80,025
New +$8.93M
NBP
93
NovaBridge Biosciences American Depositary Shares
NBP
$186M
$8.09M 0.28%
+166,896
New +$9.05M
ITCI
94
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.89M 0.27%
232,476
-133,700
-37% -$4.64M
KURA icon
95
Kura Oncology
KURA
$816M
$7.73M 0.27%
273,463
– –
TEVA icon
96
Teva Pharmaceuticals
TEVA
$40.2B
$7.62M 0.26%
660,551
-69,500
-10% -$797K
LTC
97
LTC Properties
LTC
$1.99B
$7.61M 0.26%
182,293
– –
BNTX icon
98
BioNTech
BNTX
$23.3B
$7.51M 0.26%
+68,814
New +$7.31M
CCXI
99
DELISTED
ChemoCentryx, Inc.
CCXI
$7.4M 0.25%
144,447
– –
BSX icon
100
Boston Scientific
BSX
$70.2B
$7.19M 0.25%
185,931
-60,158
-24% -$2.28M
2 3
4
5 6

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Tekla Capital Management held 226 positions worth $2.91B, up 2.1% from $2.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Tekla Capital Management's Q1 2021 filing shows 26 new, 31 increased, 48 reduced and 30 closed positions. Its largest new stake was Universal Health Services: 71,323 shares worth $9.51M. The largest sale was Alexion Pharmaceuticals, an estimated $60.5M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Real Estate and Industrials.

  • Tekla Capital Management's largest Q1 2021 buy was Universal Health Services: 71,323 shares worth $9.51M.
  • Tekla Capital Management added most to Elevance Health in Q1 2021, an estimated $41M increase.
  • Tekla Capital Management's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $60.5M.
  • Tekla Capital Management fully exited NovoCure in Q1 2021, selling an estimated $15.2M.
  • Tekla Capital Management's ten largest holdings make up 30% of its $2.91B portfolio in Q1 2021.
  • Tekla Capital Management opened 26 new positions and closed 30 in Q1 2021.
  • Tekla Capital Management's portfolio value rose 2.1% quarter-over-quarter to $2.91B.

Based on Tekla Capital Management's 13F filing for Q1 2021, filed 14 May 2021.